Pharmaceutical industry news

What's Going On With Cytokinetics Stock Today? - Cytokinetics (NASDAQ:CYTK)

FDA Approves Gilead's New Single Tablet HIV Regimen

What additives are in your food? The FDA doesn't always know, but seeks to change that

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history

Trump strikes new drug pricing deals with nine midsized drugmakers

Seattle-area biotech led by ex-Athira CEO Leen Kawas raises $35M for hepatitis D drug

After 25 Years Without a New PTSD Drug, Here's What's in the Pipeline

Craig Lipset on Decentralized Clinical Trials and the Birth of DTRA

Clinical Trial Governance: What It Is and Why It Matters

FDA calls out Alar Pharmaceuticals for promoting unapproved ketamine drug at APA meeting

Prasco Acquires 130,000-Square-Foot Ohio Facility to Expand Pharmaceutical Distribution

CVKD: Advancing Partnering Process for Cardiac Acute Critical Care Franchise

Cybin Shares Slide 4.12% as Investors Weigh Phase 3 Progress, Cash Burn and CEO Transition

Novavax Stock Climbs Monday: What's Going On?

How To Read A Biotech Clinical Trial Result: P-values, Endpoints, And Investor Implications

Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push

Prof. Miloš A. Lučić: Obituary

ESR mourns the passing of Prof. Miloš A. Lučić

ESC26: AstraZeneca's heart failure drug shows promise in ph. 2 trial

Pharmaceutical giant McKesson warns of 'service degradation' following cyberattack

Outbreak Investigation of Shiga Toxin-producing E. coli & Salmonella: Sprouts (August 2026)

Cencora's Ameer Ali on Readying Systems for NDC-12

Snakes in an egg all coil in the same direction. Scientists think they’ve learned why.

Tukaram Mundhe: Why Rule-Breakers Fear Him

Core Biogenesis and Faravelli showcase biotech-powered longevity body care

ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy

BIOTECanada Announces 2026 Gold Leaf Award Winners, Recognizing Excellence Across Canada’s Biotechnology Ecosystem

Worcester startup gets $8M NASA grant to make medicine in space

InnoCan Pharma (CN:INNO) Jumps 9.22% Today as Biotech Catalysts and Consumer-Wellness Growth Revive Bullish Momentum

Nearly 70% Of New Drugs Now Win FDA Approval With Just One Study

Co-creation for GLP-1 RTU cartridges

IDEAYA prepares Phase 3 IDE849 lung cancer trial

Moving beyond single targets in neurological repair

Kiora Licenses South Korean Rights to KIO-301 for RP to Chong Kun Dang

Traffic and Travel Advisories for Visitors

FDA Approves BESREMi for Adults with Essential Thrombocythemia

Prasco Increases Pharmaceutical Footprint in Ohio

Alnylam stock maintained at Buy by Truist on mixed trial data

First Patient Dosed in Phase 3 SUMMIT Trial of AXS-05 for Smoking Cessation

FDA authorizes generic Ivermectin shot to help prevent screwworm in cattle

What National Licensure Means for Wholesalers and 3PLs

ESC 2026: Evolocumab explores new frontiers in CV disease prevention

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies

Wall Street analysts bullish on Attovia as itch drug data fuel biotech optimism

Pharmaceutical Packaging Market Report 2026-2036 Now Available — Forecasts Market Growth from $188.4B (2026) to $436.5B by 2036, Profiling Amcor, Gerresheimer, Schott, and 53 Other Key Players

JDS Consulting Group Launches in the UAE to Deliver Engineering, Pharmaceutical and Business Innovation Expertise

Can a pregnancy hormone steer a cardiovascular treatment?

One ALS drug plan replaces a single large trial with three focused studies

NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS

Cadrenal Therapeutics (CVKD) Advances Phase 3 Trial Protocol, Fa

BMF Capital Shorts SELLAS Life Sciences, Sees 76% Downside - SELLAS Life Sciences Gr (NASDAQ:SLS)

Rhelion Life Sciences Reports First Quarter 2027 Results

RDHL Stock Volatility Draws Trader Focus As Biotech Reprices

An opioid study from Ensysce is fully enrolled to test overdose protection

Allogene Therapeutics Announces Participation in September Investor Conference

Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

80-Year-Old Pharma Veteran Returns to Hong Kong Stock Exchange: Bangshun Pharmaceutical Files for Second IPO at Nearly 2.4 Billion Yuan Valuation

Ceremony and reception commemorating the new Institute for the Evolutionary Origins of Human Behavior (EHUB)

JAMP Temozolomide: Out-of-Specification (Assay)

The active ingredient (temozolomide) is out of specification in the affected lot.

FDA agrees to a placebo trial for a drug aimed at a blood reaction affecting 50,000 yearly